Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.-Reference-Cited by-同舟云学术

Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.

Published:1980-10 Issue:19 Volume:255 Page:9021-9024
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wong P.Y.,Lee W.H.,Chao P.H.,Reiss R.F.,McGiff J.C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference24 articles.

1. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

2. Chemical stability of prostacyclin (PGI2) in aqueous solutions

3. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

4. Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De Novo Synthesis of Dihydrobenzofurans and Indolines and Its Application to a Modular, Asymmetric Synthesis of Beraprost;Journal of the American Chemical Society;2023-06-16

2. Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts;Journal of Lipid Research;2014-07

3. Eicosanoids in Mammals;Comprehensive Natural Products Chemistry;1999

4. High-Pressure Liquid Chromatography of Oxo-Eicosanoids Derived from Arachidonic Acid;Analytical Biochemistry;1997-04

5. Gastric prostaglandin E2 receptors are the common antisecretory target of mucosal prostanoids;European Journal of Pharmacology;1992-08